Pharma Journalist -

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Orencia (abatacept) for the…
Read More...

BioDuro-Sundia, a leading drug discovery and development services organization backed by Advent International, announced today it has entered into a definitive agreement to acquire a…
Read More...

Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, announced that…
Read More...

JW Therapeutics an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, announced that it has entered into a strategic…
Read More...

We are pleased to announce the Advanced RWE Applications in Pharma Summit (formerly IMPACCT) is returning on October 26-28, 2021, for its 9th year. This year we will unite the RWE…
Read More...

SMi reports: Deepen your understanding of crucial delivery methods and available platforms for non-hepatocytic delivery Join us at the Oligonucleotide Therapeutics and Delivery…
Read More...

SMi Reports: Hear from key industry players from San Francisco and the West Coast to learn about Device Innovations, Connected Delivery and Regulatory Guidance for Advanced Parenteral…
Read More...

SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore  new approaches using X ray Microscopy (XRM) from nano- to micro-scale  Webinar overview…
Read More...

BeiGene, Ltd. a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that the Center for Drug Evaluation (CDE) of the China…
Read More...

Bristol Myers Squibb announced that Opdivo(nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. Food and Drug…
Read More...